1·Results 154 times of bronchial arteriography and BAI with chemotherapeutic agent were performed in 46 pulmonary carcinomas patients.
结果本组46例中晚期肺癌病人施行154例次选择性支气管动脉造影和灌注化疗。
2·Objective To investigate the causes, treatment and prevention of damage of spinal cord in BAI with chemotherapeutic agent for pulmonary carcinomas.
目的探讨支气管动脉灌注（BAI）治疗肺癌并发脊髓损伤的原因、处理方法及预防。
3·Once a tumor has acquired resistance to a specific chemotherapeutic agent, it is common to observe collateral resistance to other structurally similar agents.
一旦肿瘤对特定的化学治疗剂具有获得性抗性之后，通常就会观察到其对其它结构类似的试剂的间接抗性。
4·Treatment with the chemotherapeutic agent bevacizumab, a humanized mab that neutralizes vascular endothelial growth factor, can lead to proteinuria and renal damage.
采用化学治疗药物(贝伐单抗，是中和血管内皮生长因子的人源化抗体)治疗可导致蛋白尿和肾功能损害。
5·However, LDN in combination with cisplatin attenuated the toxicity of this chemotherapeutic agent, indicating that LDN was protective of the adverse events elicited by a chemotherapeutic drug.
然而当LDN和顺箔一起作用时，可以减少顺箔的毒性，显示LDN对于化疗药物所产生的不良副作用有缓解的效果。
6·With the application of new chemotherapeutic agent and targeted drug, medical treatment for gastric carcinoma has made some progresses and clinical drug selection was more diversified than before.
随着近年来新型化疗和靶向药物的应用，胃癌的内科治疗水平不断提高，临床选择也日益多样化。
7·This study was designed to investigate anti tumor effects of differentiation inducing agent in combination with cytotoxic chemotherapeutic drug against glioma.
本研究旨在探讨诱导分化剂与细胞毒化疗药抗胶质瘤的联合效应。
8·ConclusionSTAT3 ASODN not only possess chemotherapeutic effect, but also can improve the sensitivity of tumor cells, making it a promising agent for future research and clinical application.
结论反义STAT 3既具有化疗效果，又具备放疗增敏作用，对提高肿瘤的放疗效果有良好的开发前景。